Clinical trial
A Randomised, Double-Blind, Repeat-Dose, Placebo-Controlled Phase IIa Proof of Concept Study to Investigate the Safety and Efficacy of Oral BBR-012 in Combination With Standard Medical Care in Diabetic Patients With Complicated Skin Ulceration on the Foot
To compare the rate of healing of DFUs, measured as percent reduction in wound area per week, after 28-days treatment with BBR-012 or placebo, in combination with standard medical therapy.
| Category | Value |
|---|---|
| Study start date | 2011-03-10 |